Anthera Pharmaceuticals, Inc.
ANTH
$0.0001
$0.000.00%
OTC PK
| 03/31/2018 | 12/31/2017 | 09/30/2017 | 06/30/2017 | 03/31/2017 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 8.09M | 2.20M | 6.08M | 11.15M | 20.65M |
| Total Receivables | -- | -- | -- | -- | 100.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 653.00K | 995.00K | 1.77M | 2.80M | 2.12M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 8.74M | 3.19M | 7.85M | 13.95M | 22.87M |
|
|
|||||
| Total Current Assets | 8.74M | 3.19M | 7.85M | 13.95M | 22.87M |
| Net Property, Plant & Equipment | 72.00K | 482.00K | 521.00K | 560.00K | 718.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 8.81M | 3.67M | 8.37M | 14.51M | 23.59M |
|
|
|||||
| Total Accounts Payable | 1.85M | 1.83M | 1.01M | 1.97M | 2.76M |
| Total Accrued Expenses | 801.00K | 2.88M | 2.97M | 2.27M | 3.37M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 2.65M | 4.71M | 3.98M | 4.25M | 6.13M |
|
|
|||||
| Total Current Liabilities | 2.65M | 4.71M | 3.98M | 4.25M | 6.13M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 704.00K | 4.46M | 4.05M | 5.70M | 14.70M |
| Total Liabilities | 3.35M | 9.17M | 8.03M | 9.95M | 20.83M |
|
|
|||||
| Common Stock & APIC | 447.61M | 428.60M | 424.77M | 422.67M | 421.15M |
| Retained Earnings | -442.15M | -434.43M | -424.76M | -418.45M | -418.76M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 5.46M | -5.83M | 10.00K | 4.23M | 2.39M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | 333.00K | 333.00K | 333.00K | 377.00K |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | 333.00K | 333.00K | 333.00K | 377.00K |
|
|
|||||
| Total Common Equity | 5.46M | -5.83M | 10.00K | 4.23M | 2.39M |
| Total Preferred Equity | -- | 333.00K | 333.00K | 333.00K | 377.00K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 5.46M | -5.50M | 343.00K | 4.56M | 2.76M |
|
|
|||||